European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

(2018) Marina Boccardi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia

(2018) Zuzana Walker et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical utility of FDG-PET for the clinical diagnosis in MCI

(2018) Javier Arbizu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

(2018) Federica Agosta et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia

(2018) Peter J. Nestor et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

(2018) Flavio Nobili et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia

(2018) Femke Bouwman et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

(2018) Alexander Drzezga et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease

(2018) Andrea Pilotto et al.   NEUROLOGY

Combination of 18F-FDG PET and Cerebrospinal Fluid Biomarkers as a Better Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment Patients

(2018) IL Han Choo et al.   JOURNAL OF ALZHEIMERS DISEASE

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

(2017) Giovanni B Frisoni et al.   LANCET NEUROLOGY

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

(2017) Günter U. Höglinger et al.   MOVEMENT DISORDERS

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

(2017) Valentina Garibotto et al.   NEUROBIOLOGY OF AGING

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

(2017) Michael J. Strong et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

123I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and123I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

(2016) Pietro Tiraboschi et al.   ANNALS OF NEUROLOGY

An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy

(2016) Michael J. Firbank et al.   BRITISH JOURNAL OF PSYCHIATRY

Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer’s Disease

(2016) Eva Louwersheimer et al.   JOURNAL OF ALZHEIMERS DISEASE

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study

(2016) M J Firbank et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases

(2016) Paul J. Mattis et al.   NEUROLOGY

Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia

(2015) Jennifer L. Whitwell et al.   BRAIN AND LANGUAGE

Classification of Parkinsonian Syndromes from FDG-PET Brain Data Using Decision Trees with SSM/PCA Features

(2015) D. Mudali et al.   Computational and Mathematical Methods in Medicine

Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages

(2015) Carlos Cabral et al.   COMPUTERS IN BIOLOGY AND MEDICINE

A Cochrane review on brain [18F]FDG PET in dementia: limitations and future perspectives

(2015) Silvia Morbelli et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study

(2015) M. Tripathi et al.   JOURNAL OF NUCLEAR MEDICINE

18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias

(2015) C. Taswell et al.   JOURNAL OF NUCLEAR MEDICINE

Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography

(2015) Sharon J Sha et al.   Alzheimers Research & Therapy

Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study

(2015) M. Pagani et al.   NeuroImage-Clinical

Evaluation of the New Consensus Criteria for the Diagnosis of Primary Progressive Aphasia Using Fluorodeoxyglucose Positron Emission Tomography

(2014) Jordi A. Matias-Guiu et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Syndrome-Specific Patterns of Regional Cerebral Glucose Metabolism in Posterior Cortical Atrophy in Comparison to Dementia with Lewy Bodies and Alzheimer's Disease-A [F-18]-Fdg Pet Study

(2014) Timo S. Spehl et al.   JOURNAL OF NEUROIMAGING

18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias

(2014) J. T. O'Brien et al.   JOURNAL OF NUCLEAR MEDICINE

Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes

(2014) Adriano Chiò et al.   LANCET NEUROLOGY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis

(2014) M. Pagani et al.   NEUROLOGY

Quantitative application of the primary progressive aphasia consensus criteria

(2014) M. R. Wicklund et al.   NEUROLOGY

Dementia with Lewy bodies: Basis of cingulate island sign

(2014) J. Graff-Radford et al.   NEUROLOGY

The El Escorial criteria: Strengths and weaknesses

(2014) Federica Agosta et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Value of18Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis

(2014) Koen Van Laere et al.   JAMA Neurology

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology

(2014) Robert Laforce et al.   NeuroImage-Clinical

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting

(2014) Daniela Perani et al.   NeuroImage-Clinical

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

(2013) Keith A. Johnson et al.   Alzheimers & Dementia

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012

(2013) M. A. Leone et al.   EUROPEAN JOURNAL OF NEUROLOGY

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia

(2013) Javier Arbizu et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Imaging markers for Alzheimer disease: Which vs how

(2013) G. B. Frisoni et al.   NEUROLOGY

FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type

(2013) Ajay Madhavan et al.   PLoS One

Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2013) Jonathan Young et al.   NeuroImage-Clinical

Metabolic brain networks in translational neurology: Concepts and applications

(2012) Martin Niethammer et al.   ANNALS OF NEUROLOGY

Visual Assessment Versus Quantitative Three-Dimensional Stereotactic Surface Projection Fluorodeoxyglucose Positron Emission Tomography for Detection of Mild Cognitive Impairment and Alzheimer Disease

(2012) Vance T. Lehman et al.   CLINICAL NUCLEAR MEDICINE

EFNS task force: the use of neuroimaging in the diagnosis of dementia

(2012) M. Filippi et al.   EUROPEAN JOURNAL OF NEUROLOGY

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

(2012) S. Sorbi et al.   EUROPEAN JOURNAL OF NEUROLOGY

18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size

(2012) Andrea Ciarmiello et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT

(2012) Shirlony Morgan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison

(2012) A. Caroli et al.   JOURNAL OF NUCLEAR MEDICINE

Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease

(2012) Katherine R. Gray et al.   NEUROIMAGE

Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses

(2012) Paule-Joanne Toussaint et al.   NEUROIMAGE

[18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism

(2012) S. Hellwig et al.   NEUROLOGY

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Factors affecting the diagnostic delay in amyotrophic lateral sclerosis

(2011) Eleonora Cellura et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration

(2011) Stefan Poljansky et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines

(2011) Jonathan Hsu et al.   Implementation Science

Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment

(2011) K. Herholz et al.   JOURNAL OF NUCLEAR MEDICINE

Brain perfusion differences in Parkinsonian disorders

(2011) Noriyuki Kimura et al.   MOVEMENT DISORDERS

Fluorodeoxyglucose positron emission tomography in Richardson's syndrome and progressive supranuclear palsy-parkinsonism

(2011) Karin Srulijes et al.   MOVEMENT DISORDERS

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD

(2011) G. D. Rabinovici et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease

(2011) Philippe Allain et al.   NEUROPSYCHOLOGIA

The Value of PET in Mild Cognitive Impairment, Typical and Atypical/Unclear Dementias: A Retrospective Memory Clinic Study

(2010) Robert Laforce et al.   American Journal of Alzheimers Disease and Other Dementias

Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) – a 20-year review: Can we do better?

(2010) John Douglas Mitchell et al.   Amyotrophic Lateral Sclerosis

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

(2010) Chris C Tang et al.   LANCET NEUROLOGY

Comparing predictors of conversion and decline in mild cognitive impairment

(2010) S. M. Landau et al.   NEUROLOGY

Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype

(2009) C. M. Kipps et al.   BRAIN

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

(2009) Andrea Varrone et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Subcortical Vascular versus Amnestic Mild Cognitive Impairment: Comparison of Cerebral Glucose Metabolism

(2009) Sang Won Seo et al.   JOURNAL OF NEUROIMAGING

The 18F-FDG PET Cingulate Island Sign and Comparison to 123I- -CIT SPECT for Diagnosis of Dementia with Lewy Bodies

(2009) S. M. Lim et al.   JOURNAL OF NUCLEAR MEDICINE

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation

(2009) Michael Schöll et al.   NEUROBIOLOGY OF AGING

Frontotemporal Dementia Mimicking Dementia With Lewy Bodies

(2008) Daniel O. Claassen et al.   Cognitive and Behavioral Neurology

Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

(2008) L. Mosconi et al.   JOURNAL OF NUCLEAR MEDICINE

Abnormal metabolic networks in atypical parkinsonism

(2008) Thomas Eckert et al.   MOVEMENT DISORDERS

Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints

(2007) Lisa Mosconi et al.   BIOLOGICAL PSYCHIATRY